Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Access to healthcare

UNITAID approves grants of $160 million, for hepatitis C, MDR-TB and malaria drugs

Editor's pick
UNITAID
7 May 2014
Hepatitis C transmission & prevention

UK - 'Eradicating hepatitis C is a realistic aim'

Editor's pick
Health Service Journal
6 May 2014
Pharmaceutical industry

Vertex ends hepatitis C investment as sales fall

Editor's pick
CNBC
2 May 2014
Elimination of hepatitis C

Eliminating Hepatitis C Within a Generation. What are you going to do about it?

Editor's pick
You Tube / Jon Derricott
30 April 2014
Pharmaceutical industry

Gilead Beats Hepatitis C Sales Estimates by $1 Billion

Editor's pick
Bloomberg
23 April 2014
Activism & civil society

International Liver Conference: activists demand affordable hepatitis C treatment

Editor's pick
HepCoalition
11 April 2014
Pharmaceutical industry

U.S. drug industry group defends price of Gilead hepatitis drug

Editor's pick
Reuters
11 April 2014
Hepatitis C treatment

WHO joins clamour to make new hepatitis C pills affordable

Editor's pick
Reuters
9 April 2014
Hepatitis C treatment

WHO issues its first hepatitis C treatment guidelines

Editor's pick
World Health Organization
9 April 2014
Hepatitis C symptoms & diagnosis

WHO Hepatitis Treatment Guidelines: UNITAID Urges Efforts to Improve Diagnosis as Key to Increase Access to Medicines

Editor's pick
UNITAID
9 April 2014
Pharmaceutical industry

Gilead Sciences: How serious is the pricing problem?

Editor's pick
Barron's
9 April 2014
Pharmaceutical industry

Express Scripts Raises Pressure on Gilead for Drug Price

Editor's pick
Bloomberg
8 April 2014
Hepatitis C transmission & prevention

First European Conference on Hepatitis C and Drug Use, Berlin, 23-24 October 2014

Editor's pick
EATG
7 April 2014
Hepatitis C treatment

Costs to public of $84,000 hep C drug ‘outrageous' - Kaiser Permanente

Editor's pick
Reuters
3 April 2014
Hepatitis C treatment

Push Comes To Shove: Gilead's $1,000 Pill Could Hurt Insurer Earnings

Editor's pick
Forbes
31 March 2014
Hepatitis C treatment

Gilead says has discounted hepatitis C drug for some health plans

Editor's pick
Reuters
31 March 2014
Hepatitis C treatment

Should Prisoners Get Expensive Hepatitis C Drugs?

Editor's pick
Stateline
25 March 2014
Hepatitis C treatment

Jurgen Rockstroh: Hepatitis highlights from CROI 2014

Editor's pick
NATAP
24 March 2014
Hepatitis C treatment

Gilead offers Egypt new hepatitis C drug at 99 percent discount

Editor's pick
Reuters
24 March 2014
Hepatitis C treatment

Hepatitis C treatments: Australia urged to subsidise 'revolutionary' new drugs

Editor's pick
ABC Online
18 March 2014
Hepatitis C treatment

Price of new hepatitis C drug questioned by U.S. medical experts

Editor's pick
CBC News
12 March 2014
Hepatitis C treatment

Merck hepatitis C drugs work in HIV co-infected patients -study

Editor's pick
Reuters
5 March 2014
Hepatitis C treatment

Fewer Americans are living with hepatitis C, because more have died

Editor's pick
Los Angeles Times
4 March 2014
Hepatitis C treatment

Could new hepatitis C drugs bust state budgets?

Editor's pick
USA Today
4 March 2014